Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say

Lenacapavir , sold as Sunlenca by US pharmaceutical giant Gilead, currently costs $42,250 for the first year. The company is being urged to make it available at a thousand times less than that price worldwide.

UNAids said it could “herald a breakthrough for HIV prevention” if the drug was available “rapidly and affordably”.

Given by injection every six months, lenacapavir can prevent infection and suppress HIV in people who are already infected.

In a trial, the drug offered 100% protection to more than 5,000 women in South Africa and Uganda, according to results announced by Gilead last month.

  • lud@lemm.ee
    2·
    3 months ago

    Here, the government negotiates the price for all medication and there is a cap of around 240 EUR per year per person. After that, all prescription medication is free.

    You also get an increasing discount the closer to the limit you get. Before you have spent roughly 120 EUR you get no discount at all.

    After that you get 50% off and after ≈ 180 EUR you get 75% and finally after ≈ 225 EUR you get 90%.

    The cap and discount system also only pay for the cheapest available (in stock) medication at the pharmacy you go to which is usually a generic alternative. You can pay the difference (usually very little) if you really want non generic. Your doctor can say generics aren’t an alternative, and if that is the case the discount obviously applies anyways.

    Prescription medication is also completely free for anyone under 18.

    This system works pretty well as far as I know. The main problem might come from the fact that people with specific and expensive medication will have to pay 240 EUR out of pocket at the beginning of each period (but nothing after that) this can be hard for some individuals. Fortunately you can ask for a partial payment in those cases.